Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations
This product is sold exclusively for in vitro and laboratory research purposes
[ref] Related article: NOS3 gene and nitric oxide Gut-brain axis: Nerves running from the brain to the intestines can move neurotransmitters and send signals in both directions
Many people feel an energy lift within a few days that builds over the following week or two
Important caveat: Side effect data comes primarily from animal studies
Our highly skilled and experienced team, led by Dr.Hegedosh], is dedicated to providing top-quality, personalized care to each and every one of our clients
US$ 28.34
US$ 25.93
US$ 29.50
US$ 27.31
US$ 21.66
US$ 24.28
US$ 28.63
